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Abstract
Purpose: The purpose of this study was to develop prioritised indicators to measure cancer patient
experience and thus guide quality improvement in the delivery of patient care.
Methods: A Delphi study, consisting of two surveys and three workshops, was employed to gather expert
opinions on the most important indicators to measure. Survey participants were 149 health professionals,
academics/technical experts and consumers. The first survey was based on a literature review which identified
105 elements of care within 14 domains of patient experience. These were rated on a 7-point Likert scale, with
‘1’ representing high importance. Elements with mean ratings between 1.0 and 2.0 were retained for the
second survey. The 43 least-important elements were omitted, four elements were revised and nine new
elements added. Consensus was defined as at least 70% of participants rating an element ‘1’ or ‘2’. Multivariate
and cluster analyses were used to develop 20 draft indicators, which were presented to 51 experts to refine and
prioritise at the three workshops.
Results: All elements in the second survey were rated ‘1’ or ‘2’ by 81% of participants. Workshop participants
agreed strongly on the four most important indicators: coordinated care, access to care, timeliness of the first
treatment, and communication. Other indicators considered highly important were follow-up care for
survivors; timeliness of diagnosis; information relating to side effects, pain and medication; comprehensibility
of information provided to patients; and needs assessment.
Conclusions: Experts identified priorities with a high level of consensus, providing a rigorous foundation for
developing prioritised indicators of quality in cancer patient experience.
Publication Details
K. E. Williams, J. Sansoni, D. Morris & C. Thompson, "A Delphi study to develop indicators of cancer patient
experience for quality improvement", Supportive Care in Cancer 26 1 (2018) 129-138.
This journal article is available at Research Online: http://ro.uow.edu.au/ahsri/864




A DELPHI STUDY TO DEVELOP INDICATORS OF CANCER PATIENT EXPERIENCE 
FOR QUALITY IMPROVEMENT 
 
Authors 
Kathryn E. Williams, Janet Sansoni, Darcy Morris and Cristina Thompson  
University of Wollongong, New South Wales, Australia 
 
Author note: 
Kathryn E. Williams, Australian Health Services Research Institute (AHSRI), 
University of Wollongong; Jan Sansoni, Australian Health Services Research Institute 
(AHSRI), University of Wollongong; Darcy Morris, Australian Health Services Research 
Institute (AHSRI), University of Wollongong; Cristina Thompson, Australian Health 
Services Research Institute (AHSRI), University of Wollongong.  
Funding for the current research was provided by the Cancer Institute of New South 
Wales. The authors wish to thank Nicole Cook and Margaret Barbouttis of the Cancer 
Institute NSW and the many experts who contributed their time to this study.  
Correspondence concerning this article should be addressed to: Kathryn Williams, 
Centre for Health Services Development, Australian Health Services Research Institute 









A DELPHI STUDY TO DEVELOP INDICATORS OF CANCER PATIENT EXPERIENCE 
FOR QUALITY IMPROVEMENT 
 
Abstract 
Purpose: To develop prioritised indicators to measure cancer patient experience and thus 
guide quality improvement in the delivery of patient care. 
 
Methods: A Delphi study, consisting of two surveys and three workshops, was employed to 
gather expert opinions on the most important indicators to measure. Survey participants were 
149 health professionals, academics/technical experts and consumers. The first survey was 
based on a literature review which identified 105 elements of care within 14 domains of 
patient experience. These were rated on a 7-point Likert scale, with ‘1’ representing high 
importance. Elements with mean ratings between 1.0 and 2.0 were retained for the second 
survey. The 43 least-important elements were omitted, four elements were revised and nine 
new elements added. Consensus was defined as at least 70% of participants rating an element 
‘1’ or ‘2’. Multivariate and cluster analyses were used to develop 20 draft indicators, which 
were presented to 51 experts to refine and prioritise at the three workshops.  
 
Results: All elements in the second survey were rated ‘1’ or ‘2’ by 81% of participants. 
Workshop participants agreed strongly on the four most important indicators: coordinated 
care; access to care; timeliness of first treatment; and communication. Other indicators 
considered highly important were: follow-up care for survivors; timeliness of diagnosis; 
information relating to side effects, pain and medication; comprehensibility of information 
provided to patients; and needs assessment. 
 




Conclusions: Experts identified priorities with a high level of consensus, providing a rigorous 
foundation for developing prioritised indicators of quality in cancer patient experience.  
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A DELPHI STUDY TO DEVELOP INDICATORS OF CANCER PATIENT EXPERIENCE 
FOR QUALITY IMPROVEMENT 
 
Patient experience indicators in cancer care allow health practitioners to identify 
opportunities for positive change in services and systems, leading to better cancer outcomes 
[1]. They can be used to benchmark performance of cancer services at state, national and 
international levels. The development of appropriate and acceptable cancer patient experience 
indicators should be informed by what matters to patients and engage health care providers 
and technical experts [1]. This article reports on the results of a structured consultation 
process using the Delphi technique to develop prioritised indicators of cancer patient 
experience. The study was commissioned by the Cancer Institute of New South Wales as an 
important step in developing systems for monitoring and improving the delivery of health 
services to cancer patients. 
A literature review was conducted to identify domains (priority areas) in which cancer 
patient experience indicators are relevant. This was an important first step because patient 
experience is a broad concept that encompasses many aspects of the organisation and 
delivery of health care [2]. Indicators may be generic and apply to patients’ experiences 
irrespective of their reasons for requiring health care, as in the principles of the Picker 
Institute [3], or specific to a condition and treatment setting, such as a cancer patient’s 
experience of radiotherapy. In some clinical fields there are many well-defined indicators of 
care quality [4, 5]; however, a recent review identified relatively few published indicators of 
cancer care [6, 7].  
A justification for the specific domains chosen for the Delphi study is provided by 
current work in Scotland, England and Canada. For example, the National Health Service 
(NHS), Scotland, aims to develop “cancer-specific … evidence-based indicators … 
underpinned by patient experiences” in order to focus quality improvement activity on the 




areas that will have most impact on survival and effective care delivery [8, p.3]. In England, 
the NHS National Cancer Patient Experience Survey (CPES) measures the experience of 
cancer patients across nine domains, including access, care coordination, communication and 
emotional support [9]. This tool has recently been adapted in Australia by the Victorian 
Comprehensive Cancer Centre [10]. Performance of the Canadian cancer control system is 
measured by indicators along the continuum of cancer control: prevention, screening, 
diagnosis, treatment and person-centred perspective [11].  
The Delphi technique has been employed to develop indicators for the quality of 
cancer care in the Netherlands [12, 13], Taiwan [14], Japan [15] and Greece [16, 17]. These 
studies used rating scales to develop a range of indicators within the following domains: 
 Communication [13, 16] 
 Physical support, symptom control [13, 15, 16] 
 Psychosocial support and care [13, 15, 16] 
 Patient-centred care, including multi-disciplinary teams [14]; shared decision making 
[15]; and care coordination, timely diagnosis and treatment, and support for self-
management [13] 
 Equity of access for patients from regional areas [16]; 
 Monitoring and surveillance during remission [13];  
 Care for families of cancer patients [15]. 
The aim of this study was to develop prioritised indicators of cancer patient 
experience for use in guiding service improvement. Patient experience was envisaged as 
covering most phases of the patient pathway (assessment, diagnosis and treatment), most care 
settings (primary care, hospital inpatient and outpatient facilities, sub-acute facilities and 
community services) and all tumour groups. In order to fulfil the aim of the study it was 




imperative to obtain a diverse range of expert views. While most commonly an expert will 
have a relevant professional or academic qualification, consumers may be considered experts 
because of their lived experience. The importance of involving consumers in the Delphi 
process has been identified [18]. Compared with providers, consumers may have different 
priorities [17]. The inclusion of patients and carers was therefore seen as appropriate and was 






The Delphi technique employs a series of surveys, interspersed with feedback to 
participants, to obtain anonymous opinions from experts. There are no universally accepted 
requirements or guidelines that specify, for example, the number of rounds or the definition 
of consensus [4]. Nevertheless, the four commonly accepted characteristics of the Delphi 
method have been incorporated into the current study: anonymity; iteration; controlled 
feedback; and statistical analysis of the group response [19]. 
 
Participants 
A purposive, criterion-based sampling approach was adopted. The participants’ 
primary criterion was their specialist knowledge, gained through experience or qualifications, 
demonstrating interest in cancer patient experience and/or patient experience measurement. 
Three categories of experts were sought: health care professionals, consumers and academics 
or technical experts. Experts were identified through professional networks of team members, 
examination of the authorship of key literature, and internet searching. Consumer 




representation was obtained through participation of key consumer groups within New South 
Wales and Australia.  
At the end of the Round 2 survey, respondents were asked to indicate their interest in 




The Round 1 questionnaire was based on a literature scan, which drew on previous 
reviews [6, 7, 20], and patient experience measures and surveys used in Australia and 
overseas. This identified 14 domains (Table 1) and 105 associated elements (specific aspects) 
of cancer patient experience. 
The questionnaire presented elements within each domain. Participants were asked 
how important it was to measure each element or domain. This instruction was repeated at 
the beginning of each section to remind participants that they should consider whether 
measuring an aspect of care could be useful to inform quality improvement activities. 
Each element within each domain was rated on a Likert-type scale from 1 High 
importance to 7 Low importance. After rating all elements in a domain, participants were 
asked to select the most important element. They were asked to comment and whether other 
(new) elements should be included in that domain. After rating all 105 elements, they were 
presented with the list of 14 domains and asked to rate them on the same seven-point scale 
used for the elements. Finally, the list of 14 domains was presented again, and participants 
were asked to select the seven most important domains and rank them in order of importance. 
The procedure of rating and ranking the domains provided further insights into patterns 
within the data set that revealed participants’ priorities, beyond those obtained by looking at 
elements in isolation. 




The questionnaire was modified following analysis of the Round 1 data. Based on 
mean ratings, 43 least important elements were eliminated. The aim of revising the 
questionnaire was to reduce participant burden and encourage consensus. Elements that had a 
mean rating of 2 or less in Round 1 were included in the Round 2 questionnaire. The cut 
point for inclusion of elements for Round 2 was chosen because a mean score of 2 or less 
indicated that most participants had rated the element as very important (lower scores = 
greater importance). The percentage of participants who rated the elements as highly 
important (i.e., a rating of ‘1’ or ‘2’) was also considered. The qualitative feedback from 
Round 1 highlighted aspects of patient care that were not adequately covered, leading to the 
revision of four elements and the creation of nine new elements. The Round 2 questionnaire 
included 71 elements within the same 14 domains. The order in which domains were 
presented was reversed to control for order effects and respondent fatigue. The questionnaires 
were piloted to ensure the task was clear and participant burden was minimised. 
 
Procedure 
The Delphi questionnaires were developed and managed using REDCap (Research 
Electronic Data Capture), a web-based application [21]. Robust security and access controls 
were in place. The study was approved by the university’s human research ethics committee. 
After approval, invitations were emailed to experts from the Deputy CEO of the 
commissioning organisation; 183 invitations for Round 1 were delivered successfully. 
In Round 2, respondents were given: (1) their own Round 1 rating for each element or 
domain (inserted automatically via a computerised process to protect confidentiality); (2) the 
percentage of respondents who gave the element or domain a rating of 1; and (3) the group 
response in Round 1: mean and standard deviation.  




The draft indicators derived from these processes were then assessed and prioritised 
by three expert groups in workshops (N=51). Participants were given 20 cards, each 
representing an indicator. They were asked to select the 10 indicators that were most 
important to measure and to sort them in order of priority, and this individual information 
was then transferred onto forms for analysis. The group’s priorities were then discussed.  
 
Data analysis 
Questionnaire responses were exported from REDCap into an Excel spreadsheet and 
SPSS for statistical analysis. Consensus (i.e., importance and agreement) was defined by 
examining the data distribution, mean, median and percent of respondents rating an element 
as highly important. To be considered important, a domain element had to obtain a mean 
rating of between 1.0 and 2.0. The percentage of participants who nominated an element as 
most important within a domain was also examined. For the domains, the ratings and the 
rankings were considered when determining relative importance. The level of agreement was 
defined as the percentage of participants who rated an element (or domain) as ‘1’ or ‘2’. At 
least 70% agreement was required for consensus. 
Hierarchical cluster analysis was used to investigate the structure of the ratings data as 
a guide to reducing the large set of elements to a smaller set of indicators. Each round of the 
Delphi survey was analysed separately. The data source for the cluster analysis was a 
similarity matrix comprising the Pearson correlations among the element ratings. Correlation 
coefficients are frequently used as similarity measures for cluster analysis in the social 
sciences [22]. Hierarchical cluster analysis was chosen because it assumes that items are 
nested within increasingly abstract categories. The technique does not generate fit statistics as 
a range of solutions are possible. Principal components and scale analyses were also 
conducted in developing measurement tools for summary indicators. 







Of the 183 invitations delivered for the Round 1 survey, 158 individuals responded 
(86%) with 149 usable responses (81%). Only respondents who had been included in Round 
1 analysis were invited to Round 2. A total of 112/149 surveys were returned (75%) and all 
were included in the analysis. A description of the Delphi respondents is provided in Table 2. 
 
Element ratings and ‘most important’ elements 
Elements that received the highest mean ratings in Round 2 are presented in Table 3, 
listed by domain. All Round 2 elements were rated as ‘1’ or ‘2’ by 81% of participants, 
indicating both high importance and high agreement. Standard deviations of mean ratings 
could be compared across the two Delphi rounds for 58 elements. For 52 elements, the 
standard deviation decreased, providing another indication of movement towards consensus.  
 
Domain ratings and rankings  
Table 4 presents the ratings of the 14 domains of patient experience in both rounds of 
the Delphi survey. Domains are listed in order of importance, with those receiving the lowest 
mean ratings (highest importance) in Round 2 presented first. The percentage of participants 
who gave a rating of either ‘1’ or ‘2’ (highly important) is shown for each domain. At least 
90% of participants gave these ratings for the top six domains in Round 2, a marked change 
from Round 1 when opinions were more varied. Table 4 also presents the percentage of 
participants who ranked each domain in their ‘top 2’ (i.e., ranked either first or second). The 
Round 2 domain rankings and ratings were highly consistent despite the constraints imposed 
by the forced-choice format of the ranking task. In both tasks the participants identified the 
same three domains – coordinated care, timeliness of care and communication by doctors – as 




the most important for measuring patient experience. Technical expertise of health 
professionals and comprehensive information provided to patients were also considered 
highly important in both ratings and rankings.  
 
Structure of the data 
In the cluster analysis, solutions offering around 20 clusters were selected as the 
original project brief specified 20 prioritised indicators. All solutions included unattached 
items that had not yet joined clusters. Solutions from the two surveys were consistent. For 
domains in which multiple important elements were identified, a procedure for developing 
summary indicators was adopted, based on previous work [8]. Other elements that remained 
unattached to clusters across the two rounds were marked out as possible stand-alone 
indicators. This resulted in a list of 20 draft indicators. 
 
Final indicators 
Four indicators were strongly endorsed by the workshop participants: coordinated 
care; access to care; timeliness of first treatment; and communication (Table 5). These 
indicators were considered the most important based on both the percentage of participants 
including them in the top ten and the mean rank data. Figure 1 shows that these indicators 
were most often ranked first, second or third by workshop participants.  
There were another eight indicators with moderate to higher levels of endorsement 
(45-63%): follow-up care/ survivorship, timeliness of diagnosis, aspects of information 
provision, needs assessment, shared decision making, and psychosocial care. At least half the 
participants included nearly all of these indicators in their top ten. The remaining 12 
indicators had lower rates of endorsement (39% or less) by the workshop participants and 
these may be considered of lesser importance. 




The workshop rankings established a priority order for the final suite of indicators 
(Table 5). The wording of the indicators was refined during the workshops and through 
subsequent discussions with the commissioning organisation.  
 
DISCUSSION 
This project identified cancer patient experience indicators that, if monitored 
regularly, could guide service improvement and practice change. Expert participants in the 
Delphi process were presented with elements and domains of cancer patient experience 
derived from the literature. They were asked to judge which were the most important to 
measure. Findings from the two rounds of Delphi surveys were used to gauge the experts’ 
priorities and to understand relationships in the data so that the large set of elements and 
domains could be reduced to a list of 20 draft indicators as required in the project brief. 
Participants in three workshops then ranked the draft indicators and their feedback was 
incorporated into the final set of prioritised indicators of cancer patient experiences.  
Cancer patient experiences were defined broadly. The resulting indicators are 
therefore generic and have wide application across a range of cancer services. Although there 
have been several published Delphi studies on cancer care quality indicators, one was specific 
to breast cancer [14] and another focused on end-of-life care [15]. Delphi research on cancer 
services in Greece focused on identifying areas in which improvement was most needed [16, 
17] whereas in the Netherlands the focus was on patient-centred cancer care [12, 13].  
Despite differences in emphasis and variations in the way the Delphi technique was 
applied, there are similarities between the sets of indicators produced by those studies and the 
current research. Most highlighted the importance of patient-centred care, including care 
coordination, opportunities for the patient to participate in care planning and decision 
making, and needs assessment to support multidisciplinary care and referral to specialist 
services where required. Psychosocial support appeared consistently across the lists of 




indicators. Other important aspects of patient experience identified in the current research 
were found in some of the previous Delphi studies. These included indicators relating to 
communication, timeliness of diagnosis and treatment, access to care, and follow-up care for 
cancer survivors. Some of these indicators, notably communication and information 
provision, are supported by other recent work such as the development of generic cancer care 
indicators for the NHS Scotland [8]. 
One sensitive methodological issue with the Delphi method is the definition of 
consensus. The investigators must decide how agreement among participants will be 
measured and, if the agreement rate is used, what cut-off will be used to define consensus. 
The method used to define consensus varied across the previous Delphi studies reviewed for 
this research. With each additional survey round, consensus is expected to increase; however, 
the potential for bias increases with respondent fatigue and attrition. There is little scientific 
evidence on which to base decisions about the optimal number of rounds [4]. Our decision to 
conduct two Delphi rounds was therefore based on previous published studies. For consensus 
to be reached, at least 70% of respondents in our study had to rate an element or domain as 
highly important (either ‘1’ or ‘2’). This criterion was consistent with the 75% agreement 
suggested by Keeney and colleagues in their review of the Delphi technique in nursing 
research [24]. Determining consensus by level of agreement is meaningful when Likert-type 
scales are used [19]. A response rate of at least 70% is recommended for Delphi studies to 
reduce the possibility of bias [25]. This was achieved and exceeded in both survey rounds.  
Use of the Delphi technique captured a wide range of views by protecting the 
anonymity of respondents. However, the sample was biased towards females and respondents 
based in New South Wales; priorities may differ in other populations. Another limitation was 
the length of the questionnaire, which included many domain elements, raising the possibility 
of order effects and respondent fatigue. The domains and elements of patient experience 




presented in the first Delphi survey were derived from a scan of the literature, which is a 
recognised alternative approach to a qualitative initial round [4, 23]. To enhance consumer 
participation, it may have been better to start with consumer focus groups to generate items; 
this is the approach taken for the Dutch Consumer Quality Index [26]. Nevertheless, the 
inclusion of a wide range of experts, including consumers, in the expert panel strengthens the 
current study [18] and may promote acceptance of the final suite of indicators. 
The commissioning organisation required a set of 20 prioritised indicators. Although 
it is not feasible to implement so many indicators immediately, the list captures a broad range 
of important aspects of patient experience, providing scope for a staged implementation 
approach. The four most highly ranked indicators are most likely to be suitable for large-scale 
implementation (for example at State level). The indicators with moderate levels of 
endorsement may have potential for use by individual services seeking to improve specific 
aspects of cancer care. Eight indicators were endorsed by 39% or less of the workshop 
sample which suggests they may not be such a high priority for implementation.  
A patient centred quality cancer system is responsive to the needs of patients, carers 
clinicians and health systems [27]. Good outcomes are defined in terms of what is valuable to 
the individual patient [27]. To serve this purpose, it is essential that patient experience 
indicators for cancer care are meaningful, measurable and modifiable. Monitoring these 
indicators must produce information to identify areas for service improvement and make a 
difference to the way cancer services are delivered and, ultimately, to cancer patient 
experiences. Consequently, as a second step in the development process, the 20 draft 
indicators were presented to three workshops for further refinement and prioritisation. A 
physical meeting following the last Delphi round is an acceptable strategy for exchanging 
views and resolving uncertainties, as long as the meeting is well structured and moderated to 
contain the influence of dominant personalities [4].  




The priorities in the final suite of indicators (Table 4) were highly consistent with 
those established during the surveys. For example, coordinated care, the highest priority 
indicator, was based on the “Coordinated and Integrated Care” domain which was most 
highly rated of all domains in both surveys. This indicator focuses on care processes 
including assistance with navigating the health system; it excludes two elements which, based 
on the cluster analysis and workshop discussions, became separate indicators: needs 
assessment and follow-up care/survivorship. The domain “Timeliness of care” rated second 
in both surveys; at the workshops, this split into two indicators, both highly ranked: 
timeliness of first treatment and timeliness of diagnosis. The cluster analysis suggested the 
two domains of “Patient centred communication” could be combined, resulting in the highly 
ranked indicator communication, which covers issues of respect, treating patients with dignity 
and considering their needs and preferences. Another aspect of patient-centred care, focusing 
on participation and empowerment, formed a separate indicator: shared decision making. 
Two domains relating to information provision, each with many elements, were distilled 
down to four indicators: information provision: side effects; care plan; information style 
(comprehensibility) and information provision (tailored and accurate). Despite the changes 
in wording and emphasis, the priority given to these issues in the workshop rankings largely 
reflects their domain and element ratings in the surveys, providing further confirmation that 
consensus has been achieved. 
The Delphi data and multivariate analyses were used to suggest measurement tools for 
some of the indicators, supported by an evidence-based rationale [28]. Further work is 
necessary to support implementation, which may include a review of information systems 
and patient experience measures to identify relevant data items and develop new data items 
where required. There is a need for research to examine the extent to which measurement of 




an indicator may contribute to change in service provision and patient outcomes and to 
identify mechanisms by which processes of service delivery affect patient outcomes. 
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Table 1 List of domains 
 Domains of patient experience included in the Delphi survey 
1 Comprehensiveness of information provided to patients 
2 Style of information provision (e.g. whether written, understandable, consistent, etc.) 
3 Patient centred communication by doctors 
4 Patient centred communication by nurses and other health professionals 
5 Technical expertise and knowledge of health professionals 
6 Coordination and integration of care 
7 Timeliness of care 
8 Patient (or advocate) involvement in shared decision making 
9 Provision of psychosocial guidance to patients 
10 Comfort factors 
11 Safety aspects 
12 Sensitivity to special needs groups by services 
13 Patient concerns about access to care 
14 Assessment of patient experience and satisfaction by services 
  




Table 2 Delphi participants’ gender, state / territory and expert category 
 Round 1 Round 2 
Demographics N % N % 
Gender     
Male 28 19 21 19 
Female 121 81 91 81 
State / territory     
Australian Capital Territory 1 1 0 0 
New South Wales 114 76 87 78 
Northern Territory 0 0 0 0 
Queensland 9 6 7 6 
South Australia 10 7 6 5 
Tasmania 1 1 1 1 
Victoria 10 1 8 7 
Western Australia 3 2 2 2 
Other  1 1 1 1 
Expert category     
Healthcare professional 57 38 37 33 
Consumer - patient 25 17 22 20 
Consumer – carer 19 13 17 15 
Academic/technical expert 48 32 36 32 
TOTAL PARTICIPANTS 149 100 112 100 
 
  




Table 3 Ratings for most important elements in Round 2 survey, by domain  







1 or 2  
Coordination and integration of care 
There is a well organised process of patient care through the care pathway 
including all treatment modalities 109 1.38 0.64 95 
There is a holistic assessment of the patient's physical, psychosocial, 
supportive care and practical assistance needs 109 1.49 0.70 94 
The patient is allocated a central point of contact to help coordinate their 
care across their pathway of cancer treatment 109 1.53 0.88 92 
The patient is assisted and guided in trying to navigate the health system as 
it pertains to their care 109 1.75 1.06 89 
The patient is referred to supportive services in a timely manner 109 1.73 0.78 93 
The patient receives regular follow-up care (surveillance and monitoring) 
after active treatment is completed* 109 1.65 0.61 93 
Timeliness of care 
The time between receiving confirmation of a cancer diagnosis and the 
commencement of the first cancer treatment 110 
1.33 0.59 96 
The time to receive a confirmed diagnosis (e.g. from GP referral to 
confirmation of diagnosis) 110 
1.45 0.79 95 
Patient centred communication by doctors 
Effective communication by doctors 107 1.37 0.83 94 
Doctors consider the patient's preferences and needs 107 1.49 0.83 92 
Doctors' answers to patient questions can be easily understood 107 1.57 0.97 89 
Doctors treat the patient with respect and dignity 107 1.48 0.93 90 
The patient has confidence and trust in the doctor(s) 107 1.57 0.99 90 
Doctors encourage the patient to ask questions 107 1.67 1.05 89 
Comprehensiveness of information provided to patients 
Information on treatment options including benefits and risks 107 1.21 0.58 96 
Information on results of treatment and prognosis 107 1.39 0.72 93 
Information on test results and diagnosis 107 1.45 0.90 90 
Information on potential side effects, both short- and long-term 107 1.41 0.69 94 
Information on pain management 107 1.48 0.78 91 
Information on medication(s) use 107 1.59 0.74 89 
Information on self-care and warning signs that may require the doctor's 
attention 107 1.50 0.77 93 
Patient centred communication by nurses and other health professionals 
Effective communication by nurses 107 1.62 0.96 89 
Nurses treat the patient with respect and dignity 107 1.48 0.93 91 
Other health professional and hospital staff treat patients with respect and 
dignity 107 1.57 0.88 92 
Nurses consider patient's preferences and needs 107 1.75 0.87 89 
The patient has confidence and trust in nurses 107 1.74 1.02 89 
Technical expertise and knowledge of health professionals 
Patients' confidence and trust in the doctors' knowledge and expertise 109 1.56 0.81 88 
Patient (or advocate) involvement in shared decision making 
The patient feels their own preferences are taken into account when 
treatment decisions are made 110 1.57 0.76 92 
The patient feels empowered by health professionals to take part in making 110 1.59 0.91 91 











1 or 2  
decisions about their care and treatment 
Patient concerns about access to care 
Patients from regional, rural or remote areas do not report disruption to or 
delays in their treatment plan due to their location 110 1.41 0.55 97 
The patient has adequate access to chemotherapy services 110 1.36 0.66 96 
The patient has adequate access to radiotherapy services 110 1.39 0.68 96 
The patient has adequate access to specialist physicians 110 1.37 0.68 96 
The patient has adequate access to hospital inpatient services 110 1.52 0.71 94 
Safety aspects 
It can be demonstrated that the patient is supported in managing their pain 
safely (including medication and other therapies) 110 1.52 0.87 90 
It can be demonstrated that the patient's medication is regularly reviewed 
and monitored 110 1.6 0.85 91 
Provision of psychosocial guidance to patients 
The patient's psychosocial needs are addressed 110 1.41 0.75 96 
The patient is referred, when appropriate, to relevant psychosocial support 
services 110 1.40 0.67 94 
Style of information provision (e.g. whether written, understandable, consistent, etc.) 
Patients receive accurate information about their cancer care 107 1.34 0.85 95 
Information provided is easy to understand 107 1.36 0.57 95 
Patients receive the amount of information they need 107 1.79 0.92 90 
A care plan for each treatment modality is recorded in the patient's medical 
record 107 1.48 0.82 93 
A copy of the care plan for each treatment modality (e.g. chemotherapy, 
radiotherapy etc.) is shared with the patient 107 1.55 0.82 93 
Assessment of patient experience and satisfaction by services 
Information regarding patient experiences is collected by the service and 
used to improve the organisation and delivery of care* 111 1.54 0.74 91 
Sensitivity to special needs groups by services 
Interpreters are available for patients when needed 110 1.43 0.94 93 
Extra assistance is provided for people with other disabling or chronic 
conditions 110 1.7 0.91 88 
The health professionals are sensitive to differences in cultural perceptions 
of cancer and its treatment* 110 1.82 0.87 88 
The health professionals are sensitive to differences in the needs of other 
special groups (e.g. elderly, people with disabilities, those with low health 
literacy, those experiencing social disadvantage, etc.)* 110 1.52 0.74 92 
Comfort factors 
Where applicable, practical and logistical issues (e.g. travel, accommodation, 
scheduling of appointments) are addressed so that patients can more easily 
access the facilities where they are receiving care 110 1.65 0.80 88 
Note. R2 = Round 2 (second survey). *These items were added or modified for Round 2 of the Delphi survey. 
Low scores indicate high importance. 
 




Table 4 Domains in order of importance* 
 Round 1 Round 2 
Domain N** Mean rating SD % rated 1 or 2 % ranked top 2 N** Mean rating SD % rated 1 or 2 % ranked top 2 
Coordination and integration of care 138 1.39 0.71 92 38 112 1.38 0.8 95 51 
Timeliness of care 138 1.43 0.71 94 26 112 1.43 0.69 95 39 
Patient centred communication by doctors 138 1.54 0.88 90 35 111 1.49 0.86 94 27 
Comprehensiveness of information provided 
to patients 
138 1.55 0.81 88 29 112 1.57 0.81 91 10 
Patient centred communication by nurses 
and other health professionals 
138 1.78 0.98 83 15 111 1.65 0.84 93 8 
Technical expertise and knowledge of health 
professionals 
138 1.97 1.2 76 20 111 1.71 0.91 90 31 
Patient (or advocate) involvement in shared 
decision making 
138 1.78 0.99 79 11 112 1.73 0.9 89 8 
Patients’ concerns about access to care 138 1.96 1.08 74 3 112 1.84 0.87 82 7 
Safety aspects of care 138 1.99 1.29 70 8 112 1.88 0.97 79 7 
Provision of psychosocial guidance to 
patients 
138 1.78 0.93 79 2 112 1.94 1.02 82 2 
Style of information provision (e.g. whether 
written, understandable, consistent, etc.) 
138 1.92 1.06 75 7 111 1.98 0.95 82 2 
Assessment of patient experience and 
satisfaction by services 
138 2.07 1.07 70 4 112 2.06 0.91 79 6 
Sensitivity to special needs groups by 
services 
138 2.03 1.17 72 0 112 2.13 1.04 69 0 
Comfort factors associated with care 138 2.49 1.22 57 0 112 2.44 0.94 61 0 
Note.* Order of domains is based on Round 2 mean ratings. Low scores indicate high importance. ** Round 1 rankings n=137, Round 2 rankings n=107. 
 




Table 5 Final suite of prioritised cancer patient experience indicators 
Rank* Indicators in rank order** 
% Ranking in 
top 10 
1 Coordinated Care: 
Patients were provided with a coordinated process of care throughout their cancer 
treatment pathways. 
96 
2 Access to Care: 
Patients had appropriate access to all necessary modalities of cancer treatment for 
their cancer (e.g. clinical, surgical, chemotherapy and radiotherapy services). 
80 
3 Timeliness of First Treatment: 
The time between patients receiving confirmation of a cancer diagnosis and the 




Patients experienced excellent communication from health professionals during their 
most recent cancer treatments. 
71 
5 Follow-up Care / Survivorship: 
Patients were provided with a follow-up care plan (including self-management 
strategies) that identified the health professionals responsible for their care 
following completion of their major cancer treatments. 
63 
6 Timeliness of Diagnosis: 
The time taken for patients to receive a confirmed cancer diagnosis (i.e. the 
‘diagnostic interval’, from the first presentation to the GP or other medical 
practitioner) was reported. 
57 
6 Information Provision (Side-effects): 
Information was provided to patients (and/or their carers) so they knew how to 
manage common side-effects from their most recent cancer treatments. 
57 
8 Information Style (Comprehensibility): 
The service provided cancer patients with individually tailored information that they 
were able to understand. 
55 
9 Needs Assessment: 
Patients’ health care needs were assessed during their cancer treatment pathways 
and responded to when needed. 
51 
10 Provision of Psychosocial Care (Patients): 
Patients’ psychosocial needs were assessed and, when relevant, referrals to support 
services occurred during their most recent cancer treatments. 
 
Provision of Psychosocial Care (Carers): 
Carers’ psychosocial needs were assessed and, when relevant, referrals to support 
services occurred. 
47 
11 Shared Decision Making: 
Patients felt as involved as they wished to be in sharing decisions about their most 
recent care and treatments for cancer. 
45 
11 Information Provision (Tailored and Accurate): 
Patients received individually tailored and accurate information from health care 
professionals on diagnosis, cancer stage and type, treatment and prognosis for their 
most recent cancer treatments. 
45 
13 Access (Location): 
Patients did not experience unnecessary or inappropriate delays in access or 
disruptions to their cancer treatment(s) due to their location. 
39 
14 Patient Experience: 
Information on patients’ experiences of cancer treatment was collected at least 
annually, including an analysis of service complaints and compliments, and this 
37 




Rank* Indicators in rank order** 
% Ranking in 
top 10 
information was used to improve service delivery. 
15 Access (Logistics): 
Logistical issues for patients (e.g. travel, accommodation) were addressed when 
scheduling appointments, to facilitate patient access to cancer treatments. 
37 
16 Doctor’s Knowledge and Expertise: 
Patients felt confidence and trust in the doctor’s knowledge and expertise for their 
most recent cancer treatments. 
33 
17 Care Plan: 
Patients were engaged in the development of their care plan for each cancer 
treatment modality they experienced and the care plan was entered into their 
medical record. 
29 
17 Safety (Pain): 
Patients’ pain was assessed and patients felt supported in managing their pain safely 
(including medication and other therapies) during their most recent cancer 
treatments. 
29 
19 Safety (Medication): 
Patients’ medications were monitored during their most recent cancer treatments. 
27 
20 Priority Population Groups: 
Individually tailored support was provided as needed for cancer patients from 
priority population groups (e.g. patients from CALD communities, patients with other 
disabling conditions, patients experiencing social disadvantage). 
25 
Note. * Bold indicates that final ranking was within the top 10 indicators. **Ranking based on combined data 
from all participants in the three consultation workshops, n=51. Where percent data is the same for two 
indicators they are given the same priority ranking. 
 




Figure 1 Ranking of the 20 draft indicators by workshop participants (n=51) 
 
 
Note. The proportion of participants who ranked a draft indicator in their top three (their three most important indicators) is represented by the black 
areas. Dark grey and mid-grey have been used to indicate the proportion of participants ranking an indicator 4th to 7th and 8th to 10th respectively. The light 
grey tails at the right of each bar represent the proportion of participants who did not assign a top ten ranking to that indicator. 
